This site has been optimized to work with modern browsers and does not fully support your version of Internet Explorer.

Asthma biologics toolkit

respiratory systemAsthma biologics can transform patient lives by reducing asthma attacks, asthma-related hospital admissions and long-term side-effects of other treatments such as oral steroids. The Accelerated Access Collaborative Asthma Biologics programme, led by the Oxford AHSN through the AHSN Network, focuses on optimising pathways that help with early identification of people with uncontrolled asthma, appropriate referral of patients needing further specialist input and supporting patients to self-administer their medicine at home. Asthma biologics is one of three current focus areas in the NHS Accelerated Access Collaborative (AAC) Rapid Uptake Products (RUP) programme.

News

Almost 1,000 join webinars supporting clinicians managing severe asthma

A series of educational webinars offering practical support to help improve care for people with severe or uncontrolled asthma attracted a combined audience of almost 1,000. Find the three recordings on this page.

In April 2021 the Oxford AHSN took the lead on a new national drive to improve medicines use and outcomes for people living with severe and uncontrolled asthma. The March 2022 educational webinars were a key part of this initiative, offering support to healthcare professionals in primary care.

The three sessions covered identifying and managing uncontrolled asthma, improving adherence to asthma treatments and the launch of a consensus pathway for uncontrolled and severe asthma care. The series was supported by the Oxford AHSN and hosted by healthcare events agency Cogora on behalf of the AHSN Network and NHS Accelerated Access Collaborative (AAC).

For information about upcoming events visit our Events and Contacts page.